Open in TheBrain

Corynebacterium diphtheriae

[Corynebacterium diphtheriae Diagnosis and Treatment | Microbiology 🧫 - YouTube]

Corynebacterium diphtheriae is a significant bacterial pathogen known for causing diphtheria, a serious infectious disease. This bacterium is of particular interest due to its historical impact on public health and its continued relevance in modern medicine.

Characteristics of Corynebacterium diphtheriae

Corynebacterium diphtheriae is a Gram-positive, non-motile, rod-shaped bacterium. It belongs to the genus Corynebacterium, which includes several other species, but C. diphtheriae is the most notable due to its pathogenicity. The bacterium is characterized by its club-shaped appearance and its ability to form a pseudomembrane in the throat of infected individuals.

Morphology and Growth

Pathogenesis and Virulence Factors

The primary virulence factor of Corynebacterium diphtheriae is the diphtheria toxin, an exotoxin that inhibits protein synthesis in host cells, leading to cell death. The toxin is encoded by the tox gene, which is carried by a lysogenic bacteriophage integrated into the bacterial genome.

Mechanism of Action

  1. Toxin Production: The bacterium produces diphtheria toxin, which is initially inactive.
  2. Activation: The toxin is cleaved into two fragments, A and B. Fragment B binds to the host cell membrane, facilitating the entry of Fragment A.
  3. Inhibition of Protein Synthesis: Fragment A inactivates elongation factor-2 (EF-2), a critical component of the protein synthesis machinery, leading to cell death.

Clinical Manifestations

Diphtheria primarily affects the respiratory tract, but it can also cause cutaneous infections. The hallmark of respiratory diphtheria is the formation of a thick, gray pseudomembrane in the throat, which can obstruct breathing.

Diagnosis and Treatment

Diagnosis

Diagnosis of diphtheria involves both clinical assessment and laboratory testing. The presence of a pseudomembrane in the throat is a strong clinical indicator. Laboratory confirmation includes:

Treatment

Prompt treatment is crucial to reduce morbidity and mortality. The mainstays of treatment are:

  1. Antitoxin: Diphtheria antitoxin neutralizes the circulating toxin but does not affect the toxin already bound to cells.
  2. Antibiotics: Penicillin or erythromycin to eradicate the bacterial infection.
  3. Supportive Care: Management of airway obstruction and other complications.

Prevention

Vaccination is the most effective way to prevent diphtheria. The diphtheria toxoid vaccine is part of the DTaP (diphtheria, tetanus, and pertussis) vaccine series given to children and the Tdap booster for adults.

Vaccination Schedule

  1. DTaP Vaccine: Administered in five doses at 2, 4, 6, 15-18 months, and 4-6 years.
  2. Tdap Booster: Recommended for adolescents and adults every 10 years.

Public Health Impact

Historically, diphtheria was a major cause of illness and death, particularly among children. The introduction of the diphtheria vaccine in the early 20th century led to a dramatic decline in cases. However, outbreaks can still occur, particularly in areas with low vaccination coverage.

Global Perspective

While diphtheria is rare in developed countries due to widespread vaccination, it remains a concern in developing regions. Efforts to improve vaccination rates and surveillance are crucial to control and prevent outbreaks.

Attachments